tradingkey.logo

Cytek Biosciences Inc

CTKB
View Detailed Chart
5.100USD
+0.030+0.59%
Close 12/26, 16:00ETQuotes delayed by 15 min
652.11MMarket Cap
LossP/E TTM

Cytek Biosciences Inc

5.100
+0.030+0.59%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.59%

5 Days

+3.03%

1 Month

-8.93%

6 Months

+43.66%

Year to Date

-21.42%

1 Year

-20.19%

View Detailed Chart

Key Insights

Cytek Biosciences Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 59/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 5.75.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Cytek Biosciences Inc's Score

Industry at a Glance

Industry Ranking
59 / 207
Overall Ranking
168 / 4563
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 5 analysts
Buy
Current Rating
5.750
Target Price
+18.31%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Cytek Biosciences Inc Highlights

StrengthsRisks
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 22.20% year-on-year.
Overvalued
The company’s latest PE is -49.67, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 80.93M shares, decreasing 0.00% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 438.00 shares of this stock.

Cytek Biosciences Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Cytek Biosciences Inc Info

Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.
Ticker SymbolCTKB
CompanyCytek Biosciences Inc
CEOJiang (Wenbin)
Websitehttps://cytekbio.com

FAQs

What is the current price of Cytek Biosciences Inc (CTKB)?

The current price of Cytek Biosciences Inc (CTKB) is 5.100.

What is the symbol of Cytek Biosciences Inc?

The ticker symbol of Cytek Biosciences Inc is CTKB.

What is the 52-week high of Cytek Biosciences Inc?

The 52-week high of Cytek Biosciences Inc is 7.300.

What is the 52-week low of Cytek Biosciences Inc?

The 52-week low of Cytek Biosciences Inc is 2.370.

What is the market capitalization of Cytek Biosciences Inc?

The market capitalization of Cytek Biosciences Inc is 652.11M.

What is the net income of Cytek Biosciences Inc?

The net income of Cytek Biosciences Inc is -6.02M.

Is Cytek Biosciences Inc (CTKB) currently rated as Buy, Hold, or Sell?

According to analysts, Cytek Biosciences Inc (CTKB) has an overall rating of Buy, with a price target of 5.750.

What is the Earnings Per Share (EPS TTM) of Cytek Biosciences Inc (CTKB)?

The Earnings Per Share (EPS TTM) of Cytek Biosciences Inc (CTKB) is -0.103.
KeyAI